Principal Financial Group
XENT

Principal Financial Group’s Intersect ENT, Inc XENT Stock Holding History

Principal Financial Group’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-188,964
Closed -$6.08M – 2297
2019
Q1 		$6.08M Buy
188,964
+7,070
+4% +$219K 0.01% 1476
2018
Q4 		$5.13M Sell
181,894
-21,059
-10% -$617K 0.01% 1498
2018
Q3 		$5.83M Buy
202,953
+34,481
+20% +$1.04M 0.01% 1554
2018
Q2 		$6.31M Buy
168,472
+151,908
+917% +$5.96M 0.01% 1521
2018
Q1 		$651K Buy
16,564
+1,524
+10% +$55.7K ﹤0.01% 1902
2017
Q4 		$487K Buy
+15,040
New +$451K ﹤0.01% 1965

Other funds holding XENT

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Principal Financial Group's XENT Position: Q2 2019 in Review

Principal Financial Group sold out of Intersect ENT, Inc (XENT) in Q2 2019, closing a stake of 188,964 shares — an estimated $6.08M sold.

Principal Financial Group first reported a position in XENT in Q4 2017 and held it in 6 quarters. The position peaked at $6.31M in Q2 2018. 112 funds tracked by Wall St. Rank hold XENT as of Q2 2019.

  • Principal Financial Group reported no remaining Intersect ENT, Inc position as of Q2 2019 after selling out during the quarter.
  • Principal Financial Group sold 188,964 Intersect ENT, Inc shares in Q2 2019, an estimated $6.08M.
  • Principal Financial Group first reported a position in Intersect ENT, Inc in Q4 2017 and held it in 6 quarters.
  • Principal Financial Group's Intersect ENT, Inc position peaked at $6.31M in Q2 2018.
  • 112 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2019.

Based on Principal Financial Group's 13F filing for Q2 2019, filed 12 Aug 2019.